Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Vertex Resource Group Reports Record Fourth Quarter and Year End 2022 Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Oculis Holding AG OCS

Healthcare Biotechnology
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:OCS)

Fundamentals Snapshot (NDAQ:OCS)

Current News (NDAQ:OCS)

Oculis to Ring Nasdaq Stock Market Opening Bell in Celebration of its Successful Listing

GlobeNewswire 21 hours ago

Oculis Completes Enrollment in Phase 3 OCS-01 OPTIMIZE Trial

GlobeNewswire 6 days ago
View More News ››

Opinion & Analysis (NDAQ:OCS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:OCS)

Be the first to post on this bullboard.

SuperBuzz Inc.

SuperBuzz Inc.

SuperBuzz Inc. is the first AI company to specialize in marketing technology. Marketers deserve a platform to streamline ...
View More »